|
US7219016B2
(en)
|
2001-04-20 |
2007-05-15 |
Yale University |
Systems and methods for automated analysis of cells and tissues
|
|
DK1392359T4
(da)
|
2001-05-11 |
2013-06-10 |
Ludwig Inst For Cancer Res Ltd |
Specifikke bindingsproteiner og deres anvendelser.
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
EP2439284B1
(en)
*
|
2004-03-31 |
2019-05-08 |
The General Hospital Corporation |
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
|
|
AU2005250484B2
(en)
*
|
2004-06-04 |
2011-08-11 |
Genentech, Inc. |
EGFR mutations
|
|
TW200617396A
(en)
*
|
2004-10-06 |
2006-06-01 |
Astrazeneca Ab |
Method
|
|
WO2006044994A2
(en)
*
|
2004-10-18 |
2006-04-27 |
Brandeis University |
Primers, probes and methods for nucleic acid amplification
|
|
WO2006070667A1
(ja)
*
|
2004-12-28 |
2006-07-06 |
Takara Bio Inc. |
Ｅｇｆｒ遺伝子変異の検出法ならびに検出キット
|
|
NZ556673A
(en)
|
2005-02-03 |
2010-03-26 |
Gen Hospital Corp |
Method for treating gefitinib and/or erlotinib resistant cancer with an EGFR inhibitor
|
|
WO2006086777A2
(en)
|
2005-02-11 |
2006-08-17 |
Memorial Sloan Kettering Cancer Center |
Methods and compositions for detecting a drug resistant egfr mutant
|
|
CA2601936C
(en)
*
|
2005-02-24 |
2014-06-17 |
Amgen Inc. |
Epidermal growth factor receptor mutations
|
|
GB0506670D0
(en)
*
|
2005-04-01 |
2005-05-11 |
Astrazeneca Ab |
Method
|
|
GB2424886A
(en)
*
|
2005-04-04 |
2006-10-11 |
Dxs Ltd |
Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
|
|
GB2427468B
(en)
|
2005-04-05 |
2011-03-02 |
Cellpoint Diagnostics |
Cell separation device and method for the detection of EpCAM positive cells
|
|
AU2006236940A1
(en)
*
|
2005-04-14 |
2006-10-26 |
Wyeth |
Use of an epidermal growth factor receptor kinase inhibitor (EGFR) in gefitinib resistant patients
|
|
SI1913157T2
(sl)
*
|
2005-06-28 |
2017-02-28 |
Genentech, Inc. |
EGFR in KRAS mutacije za napoved bolnikovega odziva na zdravljenje z EGFR inhibitorjem
|
|
CN101351563A
(zh)
*
|
2005-10-05 |
2009-01-21 |
阿斯利康(英国)有限公司 |
用于预测或监测病人对于ErbB受体药物的响应的方法
|
|
EP3488866A1
(en)
|
2005-11-04 |
2019-05-29 |
Wyeth LLC |
Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
|
|
CA2629249C
(en)
*
|
2005-11-11 |
2015-05-05 |
Boehringer Ingelheim International Gmbh |
Combination treatment of cancer comprising egfr/her2 inhibitors
|
|
CA2833706C
(en)
|
2005-11-11 |
2014-10-21 |
Boehringer Ingelheim International Gmbh |
Quinazoline derivatives for the treatment of cancer diseases
|
|
EP1988164A4
(en)
*
|
2006-02-23 |
2009-04-22 |
Univ Kanazawa Nat Univ Corp |
METHOD FOR TESTING THE SENSITIVITY OF A SOLID TUMOR AGAINST TYROSINE KINASE INHIBITOR AND TEST KIT THEREFOR
|
|
US7867775B2
(en)
*
|
2006-03-31 |
2011-01-11 |
Biodesix, Inc. |
Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
|
|
US7906342B2
(en)
|
2006-03-31 |
2011-03-15 |
Biodesix, Inc. |
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
|
|
US7736905B2
(en)
*
|
2006-03-31 |
2010-06-15 |
Biodesix, Inc. |
Method and system for determining whether a drug will be effective on a patient with a disease
|
|
US8367351B2
(en)
|
2006-05-05 |
2013-02-05 |
Historx, Inc. |
Methods for determining signal transduction activity in tumors
|
|
US8700335B2
(en)
*
|
2006-05-18 |
2014-04-15 |
Caris Mpi, Inc. |
System and method for determining individualized medical intervention for a disease state
|
|
US8768629B2
(en)
*
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
US12366585B2
(en)
|
2006-05-18 |
2025-07-22 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
US8372584B2
(en)
|
2006-06-14 |
2013-02-12 |
The General Hospital Corporation |
Rare cell analysis using sample splitting and DNA tags
|
|
AU2007260676A1
(en)
|
2006-06-14 |
2007-12-21 |
Artemis Health, Inc. |
Rare cell analysis using sample splitting and DNA tags
|
|
WO2008008500A2
(en)
*
|
2006-07-13 |
2008-01-17 |
Yale University |
Methods for making cancer prognoses based on the subcellular localization of biomarkers
|
|
CA2663599A1
(en)
*
|
2006-09-18 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Method for treating cancer harboring egfr mutations
|
|
EP2063265B1
(en)
*
|
2006-09-28 |
2022-12-14 |
Shimadzu Corporation |
Method of preparing sample for matrix-assisted laser desorption ionization mass spectrometry and matrix-assisted laser desorption ionization mass spectrometry
|
|
JP4795203B2
(ja)
*
|
2006-11-13 |
2011-10-19 |
シスメックス株式会社 |
アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム
|
|
US9090693B2
(en)
|
2007-01-25 |
2015-07-28 |
Dana-Farber Cancer Institute |
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
|
|
NZ579644A
(en)
|
2007-02-16 |
2012-05-25 |
Merrimack Pharmaceuticals Inc |
Antibodies against erbb3 and uses thereof
|
|
PL2412828T3
(pl)
*
|
2007-03-13 |
2013-11-29 |
Amgen Inc |
Mutacje K-ras i B-raf i terapia przeciwciałami anty-EGFr
|
|
US20080293055A1
(en)
|
2007-03-13 |
2008-11-27 |
Daniel Freeman |
K-ras mutations and anti-EGFr antibody therapy
|
|
JP5618549B2
(ja)
|
2007-03-15 |
2014-11-05 |
ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド |
Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US8999634B2
(en)
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
AU2008250033A1
(en)
*
|
2007-05-11 |
2008-11-20 |
Enzon Pharmaceuticals, Inc. |
RNA antagonist compounds for the modulation of HER3
|
|
WO2009005715A1
(en)
*
|
2007-06-29 |
2009-01-08 |
Yale University |
Methods for a predictive diagnostic test for tamoxifen
|
|
JP5532486B2
(ja)
|
2007-08-14 |
2014-06-25 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
Ｅｇｆ受容体を標的とするモノクローナル抗体１７５ならびにその誘導体および用途
|
|
US8022216B2
(en)
|
2007-10-17 |
2011-09-20 |
Wyeth Llc |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
|
|
AU2009212543B2
(en)
|
2008-02-01 |
2015-07-09 |
The General Hospital Corporation |
Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
|
|
DK2271767T3
(en)
*
|
2008-04-03 |
2016-08-29 |
Cb Biotechnologies Inc |
Amplikonredning-multiplex polymerase chain reaction for the amplification of multiple target
|
|
US8137919B2
(en)
*
|
2008-04-10 |
2012-03-20 |
Montefiore Medical Center |
Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
|
|
CN101445829B
(zh)
*
|
2008-04-23 |
2013-06-05 |
广州益善生物技术有限公司 |
Egfr基因突变位点的检测探针、液相芯片及其检测方法
|
|
ES2531322T3
(es)
|
2008-06-17 |
2015-03-13 |
Wyeth Llc |
Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina
|
|
EP3175853B1
(en)
|
2008-08-04 |
2023-11-01 |
Wyeth LLC |
Antineoplastic combinations of neratinib and capecitabine
|
|
KR20110044905A
(ko)
*
|
2008-08-15 |
2011-05-02 |
메리맥 파마슈티컬즈, 인크. |
치료제에 대한 세포의 반응을 예측하는 방법 및 시스템
|
|
EP3216874A1
(en)
|
2008-09-05 |
2017-09-13 |
TOMA Biosciences, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
|
US12090480B2
(en)
|
2008-09-23 |
2024-09-17 |
Bio-Rad Laboratories, Inc. |
Partition-based method of analysis
|
|
US9417190B2
(en)
|
2008-09-23 |
2016-08-16 |
Bio-Rad Laboratories, Inc. |
Calibrations and controls for droplet-based assays
|
|
US9492797B2
(en)
|
2008-09-23 |
2016-11-15 |
Bio-Rad Laboratories, Inc. |
System for detection of spaced droplets
|
|
US9598725B2
(en)
|
2010-03-02 |
2017-03-21 |
Bio-Rad Laboratories, Inc. |
Emulsion chemistry for encapsulated droplets
|
|
US9132394B2
(en)
|
2008-09-23 |
2015-09-15 |
Bio-Rad Laboratories, Inc. |
System for detection of spaced droplets
|
|
US9089844B2
(en)
|
2010-11-01 |
2015-07-28 |
Bio-Rad Laboratories, Inc. |
System for forming emulsions
|
|
US10512910B2
(en)
|
2008-09-23 |
2019-12-24 |
Bio-Rad Laboratories, Inc. |
Droplet-based analysis method
|
|
US9399215B2
(en)
|
2012-04-13 |
2016-07-26 |
Bio-Rad Laboratories, Inc. |
Sample holder with a well having a wicking promoter
|
|
GB2502409B8
(en)
|
2008-09-23 |
2014-10-15 |
Bio Rad Laboratories |
Droplet-based assay system
|
|
US12162008B2
(en)
|
2008-09-23 |
2024-12-10 |
Bio-Rad Laboratories, Inc. |
Partition-based method of analysis
|
|
US8633015B2
(en)
|
2008-09-23 |
2014-01-21 |
Bio-Rad Laboratories, Inc. |
Flow-based thermocycling system with thermoelectric cooler
|
|
US8709762B2
(en)
|
2010-03-02 |
2014-04-29 |
Bio-Rad Laboratories, Inc. |
System for hot-start amplification via a multiple emulsion
|
|
WO2011120020A1
(en)
|
2010-03-25 |
2011-09-29 |
Quantalife, Inc. |
Droplet transport system for detection
|
|
US8951939B2
(en)
|
2011-07-12 |
2015-02-10 |
Bio-Rad Laboratories, Inc. |
Digital assays with multiplexed detection of two or more targets in the same optical channel
|
|
US9764322B2
(en)
|
2008-09-23 |
2017-09-19 |
Bio-Rad Laboratories, Inc. |
System for generating droplets with pressure monitoring
|
|
US8663920B2
(en)
|
2011-07-29 |
2014-03-04 |
Bio-Rad Laboratories, Inc. |
Library characterization by digital assay
|
|
US9156010B2
(en)
|
2008-09-23 |
2015-10-13 |
Bio-Rad Laboratories, Inc. |
Droplet-based assay system
|
|
US11130128B2
(en)
|
2008-09-23 |
2021-09-28 |
Bio-Rad Laboratories, Inc. |
Detection method for a target nucleic acid
|
|
EP3075864A1
(en)
*
|
2008-10-14 |
2016-10-05 |
Caris MPI, Inc. |
Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
|
|
IL313131A
(en)
*
|
2009-02-11 |
2024-07-01 |
Caris Mpi Inc |
Molecular characterization of tumors
|
|
GB2480980A
(en)
*
|
2009-03-02 |
2011-12-07 |
Trackfive Diagnostics Inc |
Methods for predicting cancer response to EGFR inhibitors
|
|
PT3000467T
(pt)
|
2009-04-06 |
2023-03-30 |
Wyeth Llc |
Regime de tratamento utilizando neratinib para o cancro de mama
|
|
SI2451445T1
(sl)
|
2009-07-06 |
2019-07-31 |
Boehringer Ingelheim International Gmbh |
Postopek za sušenje BIBW2992, njegovih soli in trdnih farmacevtskih formulacij, ki obsegajo to aktivno sestavino
|
|
CA2767056C
(en)
|
2009-09-02 |
2018-12-04 |
Bio-Rad Laboratories, Inc. |
System for mixing fluids by coalescence of multiple emulsions
|
|
US20130029339A1
(en)
|
2009-09-09 |
2013-01-31 |
The General Hospital Corporation |
Use of microvesicles in analyzing kras mutations
|
|
WO2011031982A1
(en)
*
|
2009-09-10 |
2011-03-17 |
Myriad Genetics, Inc. |
Methods and compositions for predicting cancer therapy response
|
|
US8323883B1
(en)
|
2009-10-09 |
2012-12-04 |
Cold Spring Harbor Laboratory |
Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors
|
|
US7947653B1
(en)
|
2009-10-09 |
2011-05-24 |
Cold Spring Harbor Laboratory |
Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers
|
|
EP2498751B1
(en)
|
2009-11-09 |
2019-04-03 |
Wyeth LLC |
Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
|
|
US20120316187A1
(en)
|
2009-11-13 |
2012-12-13 |
Pangaea Biotech, S.L. |
Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
|
|
US9034658B2
(en)
|
2009-11-23 |
2015-05-19 |
The General Hospital Corporation |
Microfluidic devices for the capture of biological sample components
|
|
US10731221B2
(en)
|
2009-12-11 |
2020-08-04 |
Dignity Health |
Diagnosing IDH1 related subgroups and treatment of cancer
|
|
US20120252856A1
(en)
*
|
2009-12-11 |
2012-10-04 |
Dignity Health |
Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy
|
|
TWI405566B
(zh)
*
|
2010-02-11 |
2013-08-21 |
Univ Nat Taiwan |
薑黃素或其類似物於使用上皮細胞生長因子接受器酪胺酸激酶抑制劑之癌症醫療之用途
|
|
US8895001B2
(en)
|
2010-03-11 |
2014-11-25 |
Merrimack Pharmaceuticals, Inc. |
Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
|
|
JP2013522613A
(ja)
*
|
2010-03-18 |
2013-06-13 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
化学療法に対する応答性を予測するための方法
|
|
JP2013524169A
(ja)
|
2010-03-25 |
2013-06-17 |
クァンタライフ・インコーポレーテッド |
液滴によるアッセイ用の検出システム
|
|
JP2013524171A
(ja)
|
2010-03-25 |
2013-06-17 |
クァンタライフ・インコーポレーテッド |
液滴ベースのアッセイのための液滴の発生
|
|
CN102234683B
(zh)
*
|
2010-04-23 |
2013-07-17 |
广州益善生物技术有限公司 |
一种egfr基因突变检测液相芯片
|
|
CN101858909B
(zh)
*
|
2010-05-28 |
2013-07-03 |
广州瑞博奥生物科技有限公司 |
检测磷酸化表皮生长因子受体的试剂盒及其制备方法
|
|
AU2011305445B2
(en)
|
2010-09-24 |
2017-03-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Direct capture, amplification and sequencing of target DNA using immobilized primers
|
|
EP2623600A4
(en)
*
|
2010-09-30 |
2014-11-26 |
Lsip Llc |
EXPRESSION INHIBITOR OF A DOMINANTLY MUTANT GENE
|
|
CA2815277A1
(en)
|
2010-10-29 |
2012-05-03 |
Immunogen, Inc. |
Novel egfr-binding molecules and immunoconjugates thereof
|
|
JP5828902B2
(ja)
|
2010-10-29 |
2015-12-09 |
イミュノジェン， インコーポレイテッド |
非拮抗性ｅｇｆｒ結合分子およびその免疫複合体
|
|
WO2012065071A2
(en)
*
|
2010-11-12 |
2012-05-18 |
The Broad Institute Of Mit And Harvard |
Methods of predicting response to egfr antibody therapy
|
|
WO2012065705A1
(en)
|
2010-11-19 |
2012-05-24 |
Roche Diagnostics Gmbh |
Novel complex mutation in the epidermal growth factor receptor kinase domain
|
|
US20120164641A1
(en)
|
2010-12-22 |
2012-06-28 |
Roche Molecular Systems, Inc. |
Methods and Compositions for Detecting Mutation in the Human Epidermal Growth Factor Receptor Gene
|
|
CN102140518B
(zh)
*
|
2011-01-18 |
2013-02-06 |
杭州迪安医学检验中心有限公司 |
肺癌相关表皮生长因子受体egfr外显子突变定量检测试剂盒及方法
|
|
US8914238B2
(en)
|
2011-01-28 |
2014-12-16 |
Biodesix, Inc. |
Method for predicting breast cancer patient response to endocrine therapy
|
|
WO2012103442A2
(en)
|
2011-01-28 |
2012-08-02 |
The Broad Institute, Inc. |
Paired end bead amplification and high throughput sequencing
|
|
JP5881746B2
(ja)
|
2011-02-15 |
2016-03-09 |
ライカ バイオシステムズ ニューキャッスル リミテッド |
ｍＲＮＡの局在インサイチュー検出のための方法
|
|
US9556473B2
(en)
|
2011-02-15 |
2017-01-31 |
Leica Biosystems Newcastle Ltd |
Methods for identifying nucleic acid sequences
|
|
US12097495B2
(en)
|
2011-02-18 |
2024-09-24 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for detecting genetic material
|
|
EP2492688A1
(en)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molecular biomarkers for predicting response to antitumor treatment in lung cancer
|
|
CA2830443C
(en)
|
2011-03-18 |
2021-11-16 |
Bio-Rad Laboratories, Inc. |
Multiplexed digital assays with combinatorial use of signals
|
|
WO2012129145A1
(en)
|
2011-03-18 |
2012-09-27 |
OSI Pharmaceuticals, LLC |
Nscle combination therapy
|
|
JP2014512826A
(ja)
|
2011-04-25 |
2014-05-29 |
バイオ−ラド ラボラトリーズ インコーポレイテッド |
核酸分析のための方法および組成物
|
|
JP5930825B2
(ja)
*
|
2011-05-06 |
2016-06-08 |
アークレイ株式会社 |
Ｅｇｆｒエクソン１９多型検出試験用試薬キット及びその用途
|
|
US10466160B2
(en)
|
2011-08-01 |
2019-11-05 |
Celsee Diagnostics, Inc. |
System and method for retrieving and analyzing particles
|
|
US9404864B2
(en)
|
2013-03-13 |
2016-08-02 |
Denovo Sciences, Inc. |
System for imaging captured cells
|
|
CA2842359A1
(en)
|
2011-08-01 |
2013-02-07 |
Denovo Sciences |
Cell capture system and method of use
|
|
US9174216B2
(en)
|
2013-03-13 |
2015-11-03 |
DeNovo Science, Inc. |
System for capturing and analyzing cells
|
|
US10364464B2
(en)
|
2011-08-08 |
2019-07-30 |
The Broad Institute, Inc. |
Compositions and methods for co-amplifying subsequences of a nucleic acid fragment sequence
|
|
US9738935B2
(en)
*
|
2011-11-10 |
2017-08-22 |
Roche Molecular Systems, Inc. |
Complex mutations in the epidermal growth factor receptor kinase domain
|
|
JP2014533954A
(ja)
*
|
2011-11-21 |
2014-12-18 |
イミュノジェン， インコーポレイテッド |
Ｅｇｆｒ抗体細胞傷害性薬物複合体による、ｅｇｆｒ療法に耐性である腫瘍の治療方法
|
|
US9260714B2
(en)
|
2011-12-02 |
2016-02-16 |
Roche Molecular Systems, Inc. |
Suppression of non-specific amplification with high-homology oligonucleotides
|
|
KR101963230B1
(ko)
|
2011-12-26 |
2019-03-29 |
삼성전자주식회사 |
복수개의 단일 항체를 포함하는 단백질 복합체
|
|
EP2653558B1
(en)
|
2012-04-18 |
2015-10-07 |
Roche Diagniostics GmbH |
A method of detecting nucleic acid targets using a statistical classifier
|
|
CN102732636B
(zh)
*
|
2012-07-17 |
2014-01-15 |
海南医学院 |
一种检测肿瘤细胞egfr基因突变的芯片
|
|
CN102851375B
(zh)
*
|
2012-09-11 |
2014-02-19 |
上海源奇生物医药科技有限公司 |
检测egfr基因突变的引物、探针及其试剂盒和使用方法
|
|
KR101911438B1
(ko)
*
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
US20140341884A1
(en)
*
|
2012-12-04 |
2014-11-20 |
Roche Molecular Systems, Inc. |
Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain
|
|
US9606102B2
(en)
|
2013-01-26 |
2017-03-28 |
Denovo Sciences, Inc. |
System and method for capturing and analyzing cells
|
|
LT2964638T
(lt)
|
2013-03-06 |
2017-12-27 |
Astrazeneca Ab |
Epidermio augimo faktoriaus receptoriaus aktyvinančių mutacijų formų chinazolino inhibitoriai
|
|
US20140287417A1
(en)
|
2013-03-08 |
2014-09-25 |
Roche Molecular Systems, Inc. |
EGFR Blood Monitoring
|
|
EP2964781B1
(en)
|
2013-03-08 |
2018-01-10 |
Roche Diagnostics GmbH |
Egfr mutation blood testing
|
|
US9707562B2
(en)
|
2013-03-13 |
2017-07-18 |
Denovo Sciences, Inc. |
System for capturing and analyzing cells
|
|
US9856535B2
(en)
|
2013-05-31 |
2018-01-02 |
Denovo Sciences, Inc. |
System for isolating cells
|
|
US10391490B2
(en)
|
2013-05-31 |
2019-08-27 |
Celsee Diagnostics, Inc. |
System and method for isolating and analyzing cells
|
|
CN103333963A
(zh)
*
|
2013-06-09 |
2013-10-02 |
中国人民解放军第四军医大学 |
Egfr突变检测引物组及其用途
|
|
JP6463675B2
(ja)
*
|
2013-06-19 |
2019-02-06 |
学校法人 久留米大学 |
上皮成長因子受容体チロシンキナーゼ阻害薬の治療効果を予測する方法
|
|
AU2014287209B2
(en)
|
2013-07-09 |
2019-01-24 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
|
WO2015100459A2
(en)
|
2013-12-27 |
2015-07-02 |
Merrimack Pharmaceuticals, Inc. |
Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
|
|
US9242965B2
(en)
|
2013-12-31 |
2016-01-26 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
|
|
CN103923975B
(zh)
*
|
2014-01-27 |
2016-01-20 |
上海涌泰生物医药科技有限公司 |
一种检测egfr基因外显子19缺失突变的试剂盒和方法
|
|
WO2015178946A1
(en)
|
2014-04-04 |
2015-11-26 |
Biodesix, Inc. |
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
|
|
JP6905464B2
(ja)
*
|
2014-07-28 |
2021-07-21 |
フンダシオ インスティトゥ マー ディンヴェスティガシオンズ メディクー（イーエメイーエメ） |
上皮増殖因子受容体遺伝子の細胞外ドメインｉｉｉ内の変異
|
|
CN106795567B
(zh)
|
2014-10-09 |
2021-07-30 |
豪夫迈·罗氏有限公司 |
在表皮生长因子受体激酶结构域中的突变
|
|
KR101692044B1
(ko)
*
|
2014-12-05 |
2017-01-04 |
사회복지법인 삼성생명공익재단 |
교모세포종에서 표피 성장인자 수용체 억제제의 치료 효과를 예측하는 방법
|
|
US12595297B2
(en)
*
|
2015-05-12 |
2026-04-07 |
In3Bio Ltd. |
Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors
|
|
US10184006B2
(en)
|
2015-06-04 |
2019-01-22 |
Merrimack Pharmaceuticals, Inc. |
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
|
|
CA3001131A1
(en)
|
2015-11-02 |
2017-05-11 |
Five Prime Therapeutics, Inc. |
Cd80 extracellular domain polypeptides and their use in cancer treatment
|
|
CN108701172A
(zh)
*
|
2016-02-12 |
2018-10-23 |
南托米克斯有限责任公司 |
高通量识别患者特异性新表位作为癌症免疫疗法的治疗靶点
|
|
CN105624309B
(zh)
*
|
2016-02-23 |
2020-04-21 |
深圳华大生命科学研究院 |
检测EGFR和/或K-ras基因突变的引物、探针及试剂盒
|
|
CN105866217B
(zh)
*
|
2016-03-21 |
2018-04-10 |
杭州市红十字会医院 |
三尖杉酯碱癌症治疗效果检测装置及方法
|
|
US11261482B2
(en)
*
|
2016-05-25 |
2022-03-01 |
Gencurix Inc |
Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising same
|
|
JP2020517259A
(ja)
|
2017-04-19 |
2020-06-18 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
操作された抗原受容体を発現する免疫細胞
|
|
CN109937603B
(zh)
*
|
2017-05-03 |
2021-12-28 |
华为技术有限公司 |
基于竞争的传输方法和设备
|
|
US10299039B2
(en)
|
2017-06-02 |
2019-05-21 |
Apple Inc. |
Audio adaptation to room
|
|
CN111295245B
(zh)
|
2017-08-29 |
2021-03-16 |
伯乐实验室有限公司 |
用于分离和分析细胞的系统和方法
|
|
WO2019074920A1
(en)
*
|
2017-10-10 |
2019-04-18 |
Oncocyte Corporation |
METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF BREAST CANCER
|
|
CN109722476A
(zh)
*
|
2017-10-31 |
2019-05-07 |
北京雅康博生物科技有限公司 |
用于检测egfr基因2237-2257位突变的引物、探针及试剂盒
|
|
WO2019165121A1
(en)
|
2018-02-21 |
2019-08-29 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses therof
|
|
AU2019263233B2
(en)
*
|
2018-05-01 |
2024-08-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors which recognize mutated EGFR
|
|
WO2020080871A2
(ko)
*
|
2018-10-18 |
2020-04-23 |
(주)신테카바이오 |
암 약물 반응성 판단을 위한 바이오 마커 조성물, 바이오 마커 조성물을 이용한 암 약물 반응성 판단 방법 및 암 약물 반응성 판단을 위한 바이오 마커 조성물 검출용 진단칩
|
|
MX2021010265A
(es)
|
2019-02-26 |
2021-09-23 |
Janssen Biotech Inc |
Terapias de combinacion y estratificacion de pacientes con anticuerpos anti-egfr/c-met biespecificos.
|
|
US10633693B1
(en)
|
2019-04-16 |
2020-04-28 |
Celsee Diagnostics, Inc. |
System and method for leakage control in a particle capture system
|
|
JP7413408B2
(ja)
|
2019-05-07 |
2024-01-15 |
バイオ－ラッド ラボラトリーズ インコーポレイテッド |
自動化された単一細胞処理のためのシステムおよび方法
|
|
US11273439B2
(en)
|
2019-05-07 |
2022-03-15 |
Bio-Rad Laboratories, Inc. |
System and method for target material retrieval from microwells
|
|
MY208668A
(en)
|
2019-05-14 |
2025-05-23 |
Janssen Biotech Inc |
Combination therapies with bispecific anti-egfr/c-met antibodies and 3rd generation egfr tyrosine kinase inhibitors
|
|
US11850248B2
(en)
|
2019-05-14 |
2023-12-26 |
Yuhan Corporation |
Therapies with 3rd generation EGFR tyrosine kinase inhibitors
|
|
CN118291246A
(zh)
|
2019-06-14 |
2024-07-05 |
伯乐实验室有限公司 |
用于自动化单细胞处理和分析的系统和方法
|
|
AU2020378435B2
(en)
|
2019-11-06 |
2026-07-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and systems for analyzing nucleic acid molecules
|
|
BR112022015140A2
(pt)
|
2020-02-12 |
2022-10-11 |
Janssen Biotech Inc |
Tratamento de pacientes que têm mutações de salto do éxon 14 de c-met
|
|
US11475981B2
(en)
|
2020-02-18 |
2022-10-18 |
Tempus Labs, Inc. |
Methods and systems for dynamic variant thresholding in a liquid biopsy assay
|
|
US11211144B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Methods and systems for refining copy number variation in a liquid biopsy assay
|
|
US11211147B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
|
|
ES3040741T3
(en)
|
2020-02-24 |
2025-11-04 |
Univ Leland Stanford Junior |
Methods of analyzing cell free nucleic acids and applications thereof
|
|
CN111154881A
(zh)
*
|
2020-03-09 |
2020-05-15 |
南京实践医学检验有限公司 |
一种急性髓系白血病中基因突变的检测试剂盒及应用
|
|
US11504719B2
(en)
|
2020-03-12 |
2022-11-22 |
Bio-Rad Laboratories, Inc. |
System and method for receiving and delivering a fluid for sample processing
|
|
US20220025453A1
(en)
*
|
2020-07-23 |
2022-01-27 |
Michael Y Sha |
Xenonucleic acid-mediated multiplex qpcr clamping technology for lung cancer mutation detection
|
|
CN114107449B
(zh)
*
|
2020-08-31 |
2024-04-09 |
中山大学孙逸仙纪念医院 |
一种单细胞内原位qPCR方法
|
|
CN111996193B
(zh)
*
|
2020-09-11 |
2024-02-20 |
北京键凯科技股份有限公司 |
一种有效抑制表皮生长因子受体表达的siRNA序列
|
|
US11783912B2
(en)
|
2021-05-05 |
2023-10-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and systems for analyzing nucleic acid molecules
|
|
CN113564255A
(zh)
*
|
2021-08-13 |
2021-10-29 |
河北医科大学第四医院 |
一种lncRNA NEAT1_1的应用
|
|
DE102021126650A1
(de)
|
2021-10-14 |
2023-04-20 |
Rheinische Friedrich-Wilhelms-Universität Bonn, Körperschaft des öffentlichen Rechts |
Verfahren zur bestimmung der ansprechwahrscheinlichkeit einer malignen erkrankung auf eine behandlung mit einem pharmazeutischen hemmwirkstoff
|
|
WO2023107539A1
(en)
|
2021-12-10 |
2023-06-15 |
Bio-Rad Laboratories, Inc. |
Compositions, methods, and systems for sample processing with morphology-adjustable functionalized particles
|
|
CN114113265B
(zh)
*
|
2021-12-14 |
2023-08-08 |
郑州轻工业大学 |
一种适配体传感器及其制备方法
|
|
JPWO2023190967A1
(enExample)
*
|
2022-03-31 |
2023-10-05 |
|
|
|
TW202515577A
(zh)
*
|
2023-06-27 |
2025-04-16 |
日商大鵬藥品工業股份有限公司 |
患有具有ｅｇｆｒ畸變的非小細胞肺癌之個體的治療方法
|
|
WO2025018697A1
(ko)
*
|
2023-07-14 |
2025-01-23 |
전남대학교산학협력단 |
암 진단을 위한 시료 처리 방법 및 이를 이용한 암 진단에 대한 정보 제공 방법
|
|
CN117778322B
(zh)
*
|
2023-12-17 |
2025-02-07 |
苏州拓维生物技术有限公司 |
一种对恩杂鲁胺耐药的细胞系的筛选方法及其应用
|